← Back to Search

Virtual Reality for Muscle Spasms

N/A
Waitlist Available
Led By Chantel Burkitt, PhD
Research Sponsored by Gillette Children's Specialty Healthcare
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 days
Awards & highlights

Study Summary

This trial will test whether virtual reality can help reduce pain and anxiety during a medical procedure.

Who is the study for?
This trial is for patients at Gillette Children's Specialty Healthcare who are getting botulinum toxin injections. It's not for those who will be fully anesthetized, don't speak English, have surgery scheduled during the study, suffer from epilepsy or motion sickness, or have a ventricular shunt.Check my eligibility
What is being tested?
The trial tests if using Virtual Reality during painful medical procedures like botulinum toxin injections can reduce pain and anxiety compared to standard care. Participants are randomly chosen to receive VR or standard care while being observed.See study design
What are the potential side effects?
Since this trial involves Virtual Reality, side effects may include discomfort such as dizziness or nausea related to motion sickness but generally should be minimal.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain
Secondary outcome measures
A series of visual analogue scales (VAS) to assess pain, anxiety, satisfaction with pain management, and perceived benefits of VR.
Information collected from the medical record (e.g., medication use during procedure).
Pain
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Reality for distractionExperimental Treatment1 Intervention
The application of VR during the putative painful treatment (botulinum toxin injections) will provide a) active and engaging distraction during the procedure, and will b) block the view and auditory noise related to the procedure.
Group II: Standard of CareActive Control1 Intervention
Patients will receive the standard of care for the putative painful treatment (botulinum toxin injections).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
2017
Completed Phase 3
~1630

Find a Location

Who is running the clinical trial?

Gillette Children's Specialty HealthcareLead Sponsor
30 Previous Clinical Trials
11,453 Total Patients Enrolled
Chantel Burkitt, PhDPrincipal InvestigatorGillette Children's Specialty Healthcare
1 Previous Clinical Trials
500 Total Patients Enrolled
Chantel Barney, PhDPrincipal InvestigatorGillette Children's Specialty Healthcare
1 Previous Clinical Trials
48 Total Patients Enrolled

Media Library

Virtual Reality Clinical Trial Eligibility Overview. Trial Name: NCT03521076 — N/A
Muscle Spasms Research Study Groups: Standard of Care, Virtual Reality for distraction
Muscle Spasms Clinical Trial 2023: Virtual Reality Highlights & Side Effects. Trial Name: NCT03521076 — N/A
Virtual Reality 2023 Treatment Timeline for Medical Study. Trial Name: NCT03521076 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~8 spots leftby Mar 2025